Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tara Bancroft is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 10/29/2024 | TGTX | Buy Now | TG Therapeutics | $39.80 | 25.64% | Tara Bancroft66% | → $50 | Initiates | → Buy | Get Alert |
| 09/24/2024 | PTGX | Buy Now | Protagonist Therapeutics | $54.52 | 19.22% | Tara Bancroft66% | → $65 | Initiates | → Buy | Get Alert |
| 06/20/2024 | OCUL | Buy Now | Ocular Therapeutix | $7.37 | 49.25% | Tara Bancroft66% | $7 → $11 | Upgrade | Hold → Buy | Get Alert |
| 05/08/2024 | OCUL | Buy Now | Ocular Therapeutix | $7.37 | -5.02% | Tara Bancroft66% | $11 → $7 | Maintains | Hold | Get Alert |
| 04/29/2024 | GERN | Buy Now | Geron | $1.75 | 471.43% | Tara Bancroft66% | → $10 | Initiates | → Buy | Get Alert |
| 04/16/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Tara Bancroft66% | — | Downgrade | Buy → Hold | Get Alert |
| 03/12/2024 | OCUL | Buy Now | Ocular Therapeutix | $7.37 | 49.25% | Tara Bancroft66% | $8 → $11 | Maintains | Market Perform | Get Alert |
| 01/16/2024 | HARP | Buy Now | Harpoon Therapeutics | — | — | Tara Bancroft66% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/20/2023 | HARP | Buy Now | Harpoon Therapeutics | — | — | Tara Bancroft66% | — | Initiates | → Outperform | Get Alert |
| 08/21/2023 | MRUS | Buy Now | Merus | $46.39 | — | Tara Bancroft66% | — | Initiates | → Outperform | Get Alert |
| 08/31/2022 | BCYC | Buy Now | Bicycle Therapeutics | $9.57 | — | Tara Bancroft66% | — | Initiates | → Outperform | Get Alert |
